Topic

Pricing and market access

Pricing and market access concerns how the price of a medicine is set and the terms on which payers agree to fund it. External reference pricing benchmarks a price against other countries, access negotiation settles price and eligibility with a payer, and the 340B Drug Pricing Program is a US discount scheme.

Concepts in this topic

• 340B Drug Pricing ProgramA US federal programme requiring manufacturers to provide outpatient drugs to eligible organisations serving low-income populations at reduced prices.
• Access NegotiationAccess negotiation is the process in which a health technology supplier and a payer agree the price, eligibility and other conditions for patient access.
• Annuity PaymentAnnuity payment is an agreement to pay for a one-off therapy in yearly instalments, not upfront, with later ones sometimes stopping if the therapy fails.
• Drug PricingThe setting and negotiation of medicine prices and payments across a specified product, purchaser, market and point in the supply chain.
• External Reference PricingA medicine-pricing policy that uses prices for the same or comparable product in other jurisdictions as benchmarks for a domestic price or reimbursement decision.